These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28095982)

  • 1. What is the optimal radiotherapy schedule for limited stage small cell lung cancer?
    Slotman B
    Lung Cancer; 2017 Mar; 105():52-53. PubMed ID: 28095982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status.
    Faivre-Finn C; Falk S; Ashcroft L; Bewley M; Lorigan P; Wilson E; Groom N; Snee M; Fournel P; Cardenal F; Bezjak A; Blackhall F
    BMJ Open; 2016 Jan; 6(1):e009849. PubMed ID: 26792218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
    Sas-Korczynska B; Sokolowski A; Korzeniowski S
    Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
    Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
    Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
    Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
    Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.
    Sheikh H; Colaco R; Lorigan P; Blackhall F; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C
    Lung Cancer; 2011 Oct; 74(1):75-9. PubMed ID: 21353720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.
    Levy A; Hendriks LEL; Le Péchoux C; Falk S; Besse B; Novello S; Dingemans AC; Hasan B; Reck M; Berghmans T; Faivre-Finn C;
    Lung Cancer; 2019 Oct; 136():145-147. PubMed ID: 31520867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer.
    Halvorsen TO; Herje M; Levin N; Bremnes RM; Brustugun OT; Fløtten Ø; Kaasa S; Sundstrøm S; Grønberg BH
    Lung Cancer; 2016 Dec; 102():9-14. PubMed ID: 27987595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.
    Colaco RJ; Huh S; Nichols RC; Morris CG; D'Agostino H; Flampouri S; Li Z; Pham DC; Bajwa AA; Hoppe BS
    Acta Oncol; 2013 Apr; 52(3):506-13. PubMed ID: 23438357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of surgery in early stage small cell lung cancer: should it be re-evaluated?].
    Clemente M; Soccal PM; Rochat T; Karenovics W; Mach N; Adler D
    Rev Med Suisse; 2013 Nov; 9(407):2170, 2172-4. PubMed ID: 24354252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands.
    Damhuis R; Widder J; Senan S
    Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):17-22. PubMed ID: 29102167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in Limited-Stage Small Cell Lung Cancer.
    McCall NS; Higgins KA
    Int J Radiat Oncol Biol Phys; 2024 Oct; 120(2):343-344. PubMed ID: 39244352
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy.
    Su J; Zhu S; Liu Z; Jing S; Shen W; Li J
    Onkologie; 2012; 35(6):362-7. PubMed ID: 22722457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of small cell lung cancer: limited disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    Holbrechts S; Roelandts M;
    Rev Med Brux; 2014; 35(3):160-3. PubMed ID: 25102582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell lung cancer in a 14-year-old girl.
    Trønnes H; Haugland HK; Békássy AN; Helle SI; Sorbye H
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):e86-8. PubMed ID: 22031117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy.
    Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L
    J BUON; 2015; 20(1):146-57. PubMed ID: 25778310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in study on the therapy for limited-stage small cell lung cancer].
    Zhang H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):857-62. PubMed ID: 23982001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial.
    Colaco R; Sheikh H; Lorigan P; Blackhall F; Hulse P; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C
    Lung Cancer; 2012 Apr; 76(1):72-7. PubMed ID: 22014897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Small Cell Lung Cancer.
    Kalemkerian GP; Schneider BJ
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):143-156. PubMed ID: 27912830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.